Optimization and characterization of levamisole-loaded chitosan nanoparticles by ionic gelation method using 23 factorial design by Minitab® 15

Therapeutic Delivery

Volumn 2, Issue 2, 2011, Pages 171-179

  Shah, Divyen ^a   Londhe, Vaishali ^a  

^a Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; LEVAMISOLE; NANOPARTICLE; TRIPOLYPHOSPHATE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; FACTORIAL DESIGN; GELATION; IN VITRO STUDY; MATHEMATICAL MODEL; NANOFABRICATION; PARTICLE SIZE; PH MEASUREMENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; SUSTAINED RELEASE PREPARATION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 79954550396     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.102     Document Type: Article

References (18)

1. Look M, Bandyopadhyay A, Blum JS, Fahmy TM. Application of nanotechnology for improved response against infectious diseases in the developing world. Adv. Drug Deliv. Rev. 62, 378-393 (2010).
2. Torchilin VP. Nanoparticles for targeting lymphatics. In: Nanoparticulates as Drug Carriers. William Phillips (Ed.). Imperial College Press, London, UK, 549-608 (2006).
3. Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50, 147-160 (2000). (Pubitemid 30326694)
4. Rajapaksa TE, Stover-Hamer M, Fernandez X, Eckelhoefer HA, Lo DD. Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. J. Control. Release 142, 196-205 (2010).
5. Levamisole. Martindale, The complete drug reference (36th Edition). Sweetman SC (Ed.). Pharmaceutical Press, IL, USA 147-148 (2009).
6. Jabbar A, Zafar I, Dominique K, Muhammad G, Khan MN, Afaq M. Anthelmintic resistance: the state of play revisited. Life Sciences 79, 2413-2431 (2006). (Pubitemid 44781103)
7. Mitchell MS. Immunotherapy as part of combinations for the treatment of cancer. Int. Immunopharmacol. 3, 1051-1059 (2003). (Pubitemid 36830850)
8. Farghali H, Masek K. Immunopharmacologic agents in the amelioration of hepatic injuries. Int. J. Immunopharmacol. 20, 125-139 (1998). (Pubitemid 28355935)
9. Boyer O, Moulder JK, Grandin L, Somers MJG. Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome. Pediatr. Nephrol. 23, 575-580 (2008).
10. Donia AF, Amer GM, Ahmed HA, et al. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children. Pediatr. Nephrol. 17, 355-358 (2002). (Pubitemid 36076052)
11. Chen Y, Mohanraj VJ, Wang F, Benson HAE. Designing chitosan-dextran sulfate nanoparticles using charge ratios. AAPS PharmSciTech 8(4), Article 98 (2007).
12. Chen Y, Mohanraj VJ, Parkin JE. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Lett. Pept. Sci. 10, 621-629 (2003). (Pubitemid 40379055)
13. Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev. 69, 1638-1649 (2008).
14. Bolton S, Bon C. Factorial designs. In: Pharmaceutical Statistics, Practical and Clinical Applications (4th Edition). Bolton S, Bon C (Eds). Marcel Dekker, NY, USA 365-288 (2004).
15. Yang SJ, Shieh MJ, Lin FH, et al. Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nanoparticles. Cancer Lett. 273, 210-220 (2009).
16. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63, 125-132 (1997). (Pubitemid 127613982)
17. De Muth JE. Factorial design: an introduction. In: Basic Statistics and Pharmaceutical Statistical Applications. De Muth JE (Ed.). Marcel Dekker, NY, USA 265-194 (1999).
18. Pathak Y, Thassu D. In vitro evaluation of NPDDS. In: Drug Delivery - Nanoparticles Formulation and Characterization. Murthy RSR (Ed.). Informa Healthcare, NY, USA 156-168 (2009).